BAX vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BAX

43.3
AI Score
VS
LUNG Wins

LUNG

68.4
AI Score

Investment Advisor Scores

BAX

Oct 22, 2026
43score
Recommendation
HOLD

LUNG

Oct 22, 2026
68score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BAX LUNG Winner
Forward P/E 11.5741 28.3286 BAX
PEG Ratio 36.6767 0 Tie
Revenue Growth 5.3% -4.6% BAX
Earnings Growth 36.8% 0.0% BAX
Tradestie Score 43.3/100 68.4/100 LUNG
Profit Margin -9.3% -55.0% BAX
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD STRONG BUY LUNG

Relative Price Performance (Last 90 Days)

BAX 1M: +4.3% · 3M: +14.0% LUNG 1M: -11.2% · 3M: +50.0%

Current Technical Phase

BAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.5 · Price: $24.70

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $1.83

Fundamentals Snapshot

Metric BAX LUNG
Market Cap — —
Forward P/E 12.1 -1.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% -0.4%
EPS -1.84 -1.15
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.